Aquatic Exercise for Cognition and Mobility in Older Adults

Sponsor
Emily Dunlap (Other)
Overall Status
Recruiting
CT.gov ID
NCT05501249
Collaborator
(none)
40
1
2
12.9
3.1

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the effects of an aquatic exercise program on cognition and physical function of older adults.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Aquatic Integrated Cognitive Motor Training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of Aquatic Integrated Cognitive Motor Training on Cognition and Mobility in Older Adults
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Feb 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Aquatic Exercise Group

Aquatic class 45 minutes, 3 times a week, for 8 weeks

Behavioral: Aquatic Integrated Cognitive Motor Training
Aquatic exercise class with focus on cognitive and physical exercise

No Intervention: Control Group

Usual care for 8 weeks and one hour education session on fall prevention.

Outcome Measures

Primary Outcome Measures

  1. Stroop Effect Test: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Measure of working memory and attention

  2. Trail Making Test A and B: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Measure of visual scanning and working memory

  3. Digit Backwards Test : Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Measure of working memory capacity

  4. Gait Measurements: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    4 gait conditions (single task gait, dual task gait with head turns, dual task gait with head nods, and dual task gait count backwards by serial 7s). Gait measures collected with Strideway Gait Analysis System.

  5. Functional Outcome Measures: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Timed Up and Go Test, Cognitive Timed Up and Go Test, Single Leg Balance Test, and Four Square Step Test.

Secondary Outcome Measures

  1. Vital Sign measurements: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Blood pressure and heart rate taken after 5 min supine, immediately upon standing, and 2 min after standing

  2. Anthropometric measurements: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Height and weight

  3. Neurotrophic Growth Factors: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    Serum concentration of brain derived neurotrophic factor and insulin-like growth factor 1

  4. Numeric Pain Rating Scale: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    An 11 point scale for level of pain from 0 (no pain) to 10 (severe pain).

  5. Global Rating of Change Questionnaire: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    A 15 point global rating scale for changes in domains, from -7 (a great deal worse); through 0 (no change) to +7 (a great deal better).

  6. Activities-specific balance confidence scale: Change from baseline to the end of intervention/control period [Measures taken at baseline and again at approximately 9-10 weeks]

    A structured questionnaire that measures an individuals confidence performing daily activities. The minimum score is 0% (no confidence in balance) to 100% (complete confidence in balance).

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able to ambulate 100 ft independently with or without assistive device

  • Score greater than or equal to 3 on the Mini-Cog Test

  • Stable medical condition within one month prior to the study

  • Stable exercise program within one month prior to the study

  • Available during study testing and group class times

  • COVID-19 vaccination

  • Permission from medical provider to participate in the study

Exclusion Criteria:
  • History of dementia or Alzheimer's

  • Contraindication to exercise or pool immersion (e.g., unstable cardiovascular conditions, fever, diarrhea, aqua-phobia)

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas at Austin Austin Texas United States 78712

Sponsors and Collaborators

  • Emily Dunlap

Investigators

  • Principal Investigator: Emily Dunlap, BS, The University of Texas at Austin

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Emily Dunlap, Principal Investigator, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT05501249
Other Study ID Numbers:
  • STUDY00001403
First Posted:
Aug 15, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emily Dunlap, Principal Investigator, University of Texas at Austin
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2022